1. Signaling Pathways
  2. MAPK/ERK Pathway
    Stem Cell/Wnt
  3. ERK
  4. ERK Inhibitors

ERK Inhibitors

ERK

ERK1

ERK2

ERK5

ERK8

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

ERK Inhibitors & Activators
Product Name ERK ERK1 ERK2 ERK5 ERK8 Purity
PD98059  
ERK1
ERK2
    99.94%
SCH772984  
ERK1, IC50: 4 nM
ERK2, IC50: 1 nM
    98.69%
TBHQ
ERK
        ≥98.0%
Tauroursodeoxycholate Sodium
ERK
        98.63%
Honokiol  
ERK1
ERK2
    99.90%
Rineterkib  
ERK1
ERK2
    99.21%
ERK-IN-3 benzenesulfonate  
ERK1
ERK2
   
Ravoxertinib  
ERK1, IC50: 6.1 nM
ERK2, IC50: 3.1 nM
    99.75%
Ulixertinib    
ERK2, IC50: 0.3 nM (at KM ATP (60 μM))
    99.92%
LY3214996  
ERK1, IC50: 5 nM
ERK2, IC50: 5 nM
    99.54%
Astragaloside IV  
ERK1
ERK2
    ≥98.0%
Tauroursodeoxycholate
ERK
        ≥98.0%
Piperlongumine  
ERK1
ERK2
    99.19%
BIX02189      
ERK5, IC50: 59 nM
  99.99%
FR 180204  
ERK1, Ki: 0.31 μM
ERK1, IC50: 0.51 μM
ERK2, Ki: 0.14 μM
ERK2, IC50: 0.33 μM
    99.59%
Lidocaine
ERK
        ≥98.0%
Pluripotin  
ERK1, Kd: 98 nM
      98.86%
XMD8-92      
BMK1, Kd: 80 nM
  99.93%
AX-15836      
ERK5, IC50: 8 nM
  99.96%
VX-11e    
ERK2, Ki: 2 nM
    99.12%
Lidocaine hydrochloride
ERK
        99.46%
LM22B-10
ERK
        98.60%
Mogrol  
ERK1
ERK2
    ≥98.0%
trans-Zeatin
ERK
        99.69%
BAY885      
ERK5, IC50: 35 nM
  99.15%
KO-947  
ERK1
ERK2
    99.45%
MK-8353  
ERK1, IC50: 23 nM
ERK2, IC50: 8.8 nM
    98.79%
Pachymic acid
ERK
        ≥99.0%
XMD17-109      
ERK5, IC50: 162 nM
  ≥98.0%
Magnolin  
ERK1, IC50: 87 nM
ERK2, IC50: 16.5 nM
    99.98%
CC-90003  
ERK1
ERK2
    99.41%
BIX02188      
ERK5, IC50: 810 nM
  99.49%
Longdaysin    
ERK2, IC50: 52 μM
    99.92%
ERK5-IN-2      
ERK5, IC50: 0.82 μM
ERK5 MEF2D, IC50: 3 μM
  98.67%
C16-PAF
ERK
        ≥98.0%
Corynoxeine  
ERK1
ERK2
    99.91%
DEL-22379    
ERK2, IC50: 0.5 μM
    99.73%
Methylthiouracil  
ERK1
ERK2
    ≥98.0%
Methylnissolin  
ERK1
ERK2
    99.64%
2,5-Dihydroxyacetophenone  
ERK1
ERK2
    99.56%
Ravoxertinib hydrochloride  
ERK1, IC50: 6.1 nM
ERK2, IC50: 3.1 nM
    98.99%
ERK5-IN-1      
ERK5, IC50: 87 nM
  99.92%
ERK1/2 inhibitor 2  
ERK1
ERK2
    99.61%
ERK-IN-3  
ERK1
ERK2
    98.44%
CHPG
ERK
        ≥99.0%
ERK1/2 inhibitor 1    
ERK2, IC50: 3.0 nM
    99.16%
Deltonin  
ERK1
ERK2
    ≥99.0%
CK2/ERK8-IN-1        
ERK8, IC50: 0.5 μM
≥99.0%
JWG-071      
ERK5, IC50: 88 nM
  99.78%
Omtriptolide
ERK
        98.23%
Cafestol
ERK
        99.91%
Hypothemycin  
ERK1, Ki: 8.4 μM
ERK2, Ki: 2.4 μM
    ≥98.0%
Cearoin
ERK
        ≥98.0%
CHPG sodium salt
ERK
       
ERK2 IN-1    
ERK2, IC50: 7 nM
   
ERK-IN-2    
ERK2, IC50: 1.8 nM
   
Bohemine    
ERK2, IC50: 52 μM
    ≥98.0%
Enniatin B1
ERK
       
Enniatin B
ERK
       
Enniatin A1
ERK